10 April 2022 : Clinical Research
Organ-Sparing Pancreatectomy for Benign or Low-Grade Malignant Pancreatic Tumors: A Single-Center Experience with 101 Consecutive Patients
Kang Fang1ABCE, Gen Sun1ACE, Ming Zha1BF, Shuju Tu1CD, Yuanpeng Xiong1DF, Siqing Yi1BF, Yonghao Ouyang2BC, Yong Li1AD, Weidong Xiao1ACEG*DOI: 10.12659/MSM.935685
Med Sci Monit 2022; 28:e935685
Table 1 Patients’ characteristics.
| Variables | EN (n=40) | CP (n=22) | SPDP (n=25) | PPPD (n=7) | DPPHR (n=7) |
|---|---|---|---|---|---|
| Gender (M/F) | 12/28 | 6/16 | 4/21 | 2/5 | 3/4 |
| Age (years) | 45.3±16.8 | 43.4±14.7 | 43.2±16.2 | 50.9±17.2 | 53.4±10.3 |
| Diagnosis | |||||
| Insulinoma | 30 | 2 | 4 | 0 | 0 |
| SCN | 1 | 5 | 5 | 2 | 1 |
| MCN | 0 | 0 | 1 | 0 | 0 |
| SPN | 6 | 9 | 7 | 3 | 1 |
| NF-pNET | 2 | 3 | 1 | 0 | 2 |
| IPMN | 0 | 0 | 1 | 2 | 3 |
| Cyst | 1 | 0 | 5 | 0 | 0 |
| Pseudocyst | 0 | 1 | 0 | 0 | 0 |
| Paraganglioma | 0 | 1 | 0 | 0 | 0 |
| Granulomatous inflammation | 0 | 1 | 0 | 0 | 0 |
| Acinar cell cystadenoma | 0 | 0 | 1 | 0 | 0 |
| Tumor size (cm) | 2.7±2.1 | 4.3±2.4 | 4.4±2.6 | 3.4±2.0 | 3.5±1.7 |
| Preoperative type 2 DM | 1 | 1 | 2 | 2 | 0 |
| Minimally invasive approach | 6 | 7 | 9 | 0 | 2 |
| SCN – serous cystadenomas; MCN – mucinous cystadenomas; SPN – solid pseudopapillary neoplasms; NF-pNET – non-function pancreatic neuroendocrine tumor; IPMN – intraductal papillary mucinous neoplasms; DM – diabetes mellitus. | |||||